Future nonmelanoma skin cancer development following immune checkpoint inhibitor therapy
A TriNetX real-world study.
Kasheri E, Kincaid C, Fan X, Smith J
Journal of the American Academy of DermatologyIn the feed 7 Jul 2026, published online 31 Jul 2026, issue 2026 Jul 31, added to PubMed 7 Jul 2026
Topics: Skin cancer & tumorsBasal & squamous cell carcinomaCancer drugs
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42413777 · DOI 10.1016/j.jaad.2026.07.007